BioSpace News Archive

WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, is pleased to announce the appointment of Jeff George, global healthcare executive and investor, to the company’s board of directors, effective August 12, 2020.

- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the second quarter ended June 30, 2020 and provided a company update. “During the second quarter, we continued to execute on key strategic and operational objectives, despite the challenges presented by the COVID-19 pandemic,” said Sabrina Martucci Johnson, President and CEO of Daré Bioscience. “Importantly, we initiated the DARE-BVFRE

The funds enable ImmunoScape to bring its unique immune-profiling capability to major biopharma companies globally, accelerating development of vital immunotherapies and other medicines [12-August-2020] SINGAPORE and SAN DIEGO , Aug. 12, 2020 /PRNewswire/ -- ImmunoScape ( www.ImmunoScape.com ), a biotech firm enabling unprecedented insights into the human immune sys

Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced a collaboration with GoodMill

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and products, today announced the U.S. Food and Drug Admi

Seattle Genetics Announces TUKYSA ® (tucatinib) Approved Within Months for All Countries Participating in FDA’s Project Orbis Initiative - Australia Joins U.S., Switzerland, Canada and Singapore in Approval of TUKYSA for the Treatment of Patients with Locally Advanced or Metastatic HER2-Positive Breast Cancer -

Halberd Corp. (OTC PINK:HALB) today announced the addition of Edson Brito to the Scientific Advisory Board. Mr. Brito is CEO and Chief Business Development Officer of Cellybri Advanced Therapies in Brazil.

Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced a research collaboration with Dartmouth-Hitchcock Health (D-HH) to launch a clinical study of the Sherlock™ CRISPR SARS-CoV-2 kit for the detection of the novel coronavirus that causes COVID-19

LASEROPTEK Co., Ltd., a developer and manufacturer of world-class laser devices for aesthetic and medical dermatology, is pleased to announce the launch of its PALLAS Solid-State 311nm UVB laser in the United States

Epirium Bio Announces Commencement of Phase 1 Clinical Trial of EPM-01 in Becker Muscular Dystrophy -- Additionally, European Commission Grants Investigational Medicine EPM-01 Orphan Designation for the Potential Treatment of Becker Muscular Dystrophy --